FOCIS 2025

Myllia will be attending FOCIS 2025 in Boston to present VISTA - the new pooled CRISPR screening platform in primary human myeloid cells

Join Sumit Pawar, Myllia’s Associate Director of R&D at the FOCIS 2025 Annual Meeting! Are you interested in immunology and inflammation (I&I), with a particular focus on target discovery in primary myeloid cells?

If so, please get in touch with Myllia directly:

We’ve developed VISTA – the new CRISPR screening platform enabling target discovery in primary human macrophages and dendritic cells!

Press release about Myllia’s VISTA platform (June 6, 2025):
Myllia unveils the VISTA platform enabling CRISPR screens in human myeloid cells

Attendee(s):
Sumit Pawar (LinkedIn)

Event website:
FOCIS 2025